Meta-Analysis
Copyright ©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Oncol. Dec 15, 2023; 15(12): 2197-2211
Published online Dec 15, 2023. doi: 10.4251/wjgo.v15.i12.2197
Intensive follow-up vs conventional follow-up for patients with non-metastatic colorectal cancer treated with curative intent: A meta-analysis
Li-Li Cui, Shi-Qi Cui, Zhong Qu, Zhen-Qing Ren
Li-Li Cui, Department of Operating Room, Jiangsu Taizhou People’s Hospital, Taizhou 225300, Jiangsu Province, China
Shi-Qi Cui, Department of Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, Zhejiang Province, China
Zhong Qu, Department of Endoscopy Center, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou 310020, Zhejiang Province, China
Zhen-Qing Ren, Department of Nursing, Jiangsu Taizhou People’s Hospital, Taizhou 225300, Jiangsu Province, China
Author contributions: Cui LL and Ren ZQ conceived the study concept and participated in its design, data extraction, statistical analysis; Cui LL, Cui SQ, Qu Z, and Ren ZQ contributed to the manuscript drafting, and editing; Cui SQ and Qu Z participated in the literature research; and all authors read and approved the final manuscript.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
PRISMA 2009 Checklist statement: The authors have read the PRISMA 2009 Checklist, and the manuscript was prepared and revised according to the PRISMA 2009 Checklist.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhen-Qing Ren, MA, Department of Nursing, Jiangsu Taizhou People’s Hospital, No. 366 Taihu Road, Pharmaceutical and High-tech Zone, Taizhou 225300, Jiangsu Province, China. 635818285@qq.com
Received: June 21, 2023
Peer-review started: June 21, 2023
First decision: September 6, 2023
Revised: September 22, 2023
Accepted: October 30, 2023
Article in press: October 30, 2023
Published online: December 15, 2023
ARTICLE HIGHLIGHTS
Research background

Colorectal cancer (CRC) is the third most frequently diagnosed cancer, and the prognosis of CRC at early stage was relative better. The frequency and content of follow-up strategies play an important role on the prognosis of CRC, and intensive follow-up may improve the prognosis of CRC.

Research motivation

Assess the effects of intensive with conventional follow-up strategies for CRC patients after curative intention using a meta-analysis.

Research objectives

This study aimed to compare the overall survival, cancer-specific survival, relapse-free survival, salvage surgery, recurrence, and interval recurrences between intensive and conventional follow-up strategies for non-metastatic CRC treated with curative intent.

Research methods

The eligible trials were identified from PubMed, Embase, and the Cochrane Library databases from inception until April 2023. All of pooled analyses were calculated using the random-effects model, which considering the underlying varies across included trials.

Research results

We noted intensive follow-up play a beneficial effects in improving overall survival, and interval recurrence as compared with conventional follow-up. Moreover, the incidence of salvage surgery was significantly increased for patients received intensive follow-up.

Research conclusions

This study found intensive follow-up was superior than conventional follow-up for CRC patients after curative intention, which should introduce in clinical practice.

Research perspectives

The results of this study based on randomized controlled trials, and the evidence level for pooled conclusions was high.